An Emergency Department-To-Home Intervention to Improve Quality of Life and Reduce Hospital Use
3. Januar 2019 aktualisiert von: University of Florida
The purpose of this study is to determine if assigning older, chronically ill patients a healthcare coach after they leave the Emergency Department (ED) improves their quality of life and reduces the need for hospital-based care.
Studienübersicht
Status
Abgeschlossen
Intervention / Behandlung
Detaillierte Beschreibung
Investigators will review the ED electronic medical record in real-time to determine ED patients' study eligibility. Older, chronically ill ED patients who are eligible and agree to participate in the study will be randomly assigned to a healthcare coach and Care Transition Intervention or usual, post-ED care.
At the time of enrollment, all subjects will be asked to provide informed consent for study investigators to request Medicare Claims to determine how many ED visits, hospital admissions and doctor office visits the subject had at least 30 days after the index ED visit. All research participants will be asked basic personal information such as age, race, sex, employment and marital status. All subjects will be asked to complete a baseline survey about their quality of life.
If the subject is assigned to the Care Transition Intervention, the healthcare coach will visit the subject at home within 3 days of the ED visit. The coach will talk with the subject about following up with a regular, personal doctor and symptoms that indicate a worsening health condition. The coach will help the subject understand their medicines and help the subject make a personal health record (PHR). The coach will tell the subject about the Area Agency on Aging. If the subject receives usual care, they but will be given the usual discharge instructions from the ED nurse and doctor. If the subject receives the Care Transition Intervention, the coach will also call the subject at least 3 times after the ED visit and review the same items listed above.
All enrolled subjects will be asked to complete a phone survey within 31-60 days of the ED visit. This survey will again ask subjects about their quality of life.
Studientyp
Interventionell
Einschreibung (Tatsächlich)
1101
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
Florida
-
Gainesville, Florida, Vereinigte Staaten, 32608
- UF Health
-
Jacksonville, Florida, Vereinigte Staaten, 32209
- UF Health
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
60 Jahre und älter (Erwachsene, Älterer Erwachsener)
Akzeptiert gesunde Freiwillige
Nein
Studienberechtigte Geschlechter
Alle
Beschreibung
Inclusion Criteria:
- 60 years of age or older
- Medicare beneficiaries
- Community dwelling
- Reside within defined geographical area (to enable home visits)
- Have a working telephone
- Have at least one of the following conditions documented in their electronic medical record: congestive heart failure, chronic obstructive pulmonary disease, coronary artery disease, diabetes, stroke, pneumonia, medical and surgical back conditions (predominantly spinal stenosis), hip fracture, peripheral vascular disease, cardiac arrhythmias, deep venous thrombosis, pulmonary embolism, peptic ulcer disease or hemorrhage
Exclusion Criteria:
- Current diagnosis of psychosis
- Cancer
- Dialysis
- History of organ transplantation
- Dementia without a live-in caregiver, or
- In hospice care
- Reside outside the defined geographical area
- Reside in a skilled nursing or assisted living facility
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: ED-to-home care transition intervention
The ED-to-home care transition intervention is a coaching intervention.
It is a 4-week program that uses an Area Agency on Aging healthcare coach to conduct a home visit and at least 3 follow-up phone calls to help patients develop the skills needed for self-management and to communicate with healthcare providers.
|
The Area Agency on Aging coach's role is to build self-management capabilities for the patient and their caregiver.
During each contact, the coach reviews the four components of the Care Transition Intervention: 1: Follow-up Medical Visit.
2: Knowledge of Red Flag Symptoms.
3: Medication Reconciliation.
4: The Personal Health Record (PHR).
The coach assists patients use the PHR to document and maintain vital information and to communicate with providers.
Andere Namen:
|
|
Experimental: Usual Care
Patients randomized to usual care will receive verbal and written discharge instructions from the treating ED physician and nurse as is the standard of care.
|
Patients randomized to usual care will receive verbal and written discharge instructions from the treating ED physician and nurse as is the standard of care.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Physical Function Between Baseline and 60 Days Post-ED Visit
Zeitfenster: Baseline up to 60 days after index ED Visit
|
PROMIS Physical Function instruments measure self-reported capability.
Each of 7-items in the physical function instrument used in this study has five response items ranging in value from one to five.
Thus, the minimum score for the Physical Function Instrument used is 7 and the maximum score is 35.
The raw score is translated to a T-score using PROMIS conversion tables.
The T-score rescales the raw score into a standardized score with a mean of 50 and standard deviation of 10.
A higher PROMIS T-score represents more of the concept being measured.
For positively-worded concepts like Physical Function, a T-score of 60 is one SD better than average.
A Physical Function T-score of 40 is one SD worse than average.
Change in Physical Function is the difference between baseline and 60 day T-score.
|
Baseline up to 60 days after index ED Visit
|
|
Change in Anxiety Between Baseline and 60 Days Post-ED Visit
Zeitfenster: Baseline up to 60 days after index ED Visit
|
PROMIS Anxiety instruments measure self-reported fear, anxious misery, and hyperarousal.
Each of 8-items in the Anxiety Instrument used in this study has five response items ranging in value from one to five.
Thus, the minimum score for the Anxiety Instrument used is 8 and the maximum score is 40.
The raw score is translated to a T-score using PROMIS conversion tables.
The T-score rescales the raw score into a standardized score with a mean of 50 and standard deviation of 10.
A higher PROMIS T-score represents more of the concept being measured.
For negatively-worded concepts like Anxiety, a T-score of 60 is one SD worse than average and an Anxiety T-score of 40 is one SD better than average.
|
Baseline up to 60 days after index ED Visit
|
|
Change in Informational Support Between Baseline and 60 Days Post-ED Visit
Zeitfenster: Baseline up to 60 days after index ED Visit
|
PROMIS Informational Support instruments measure perceived availability of helpful information or advice.
Each of 5-items in the Informational Support Instrument used in this study has five response items ranging in value from one to five.
Thus, the minimum score for the Informational Support Instrument used is 5 and the maximum score is 25.
The raw score is translated to a T-score using PROMIS conversion tables.
The T-score rescales the raw score into a standardized score with a mean of 50 and standard deviation of 10.
A higher PROMIS T-score represents more of the concept being measured.
For positively-worded concepts like Informational Support, a T-score of 60 is one SD better than average and a T-score of 40 is one SD worse than average.
|
Baseline up to 60 days after index ED Visit
|
|
Number of Participants With Outpatient Visit Claims
Zeitfenster: Within 30 days after index ED visit
|
This outcome was determined by assessing the number of participants who had one or more Medicare claims for an outpatient visit in the 30 days after the index ED visit.
|
Within 30 days after index ED visit
|
|
Number of Participants With ED Visit Claims
Zeitfenster: Within 30 days after index ED visit
|
This outcome was determined by assessing the number of participants who had one or more Medicare claims for an ED visit in the 30 days after the index ED visit.
|
Within 30 days after index ED visit
|
|
Number of Participants With In-patient Admission Claims
Zeitfenster: Within 30 days after index ED visit
|
This outcome was determined by assessing the number of participants who had one or more Medicare claims for a hospitalization in the 30 days after the index ED visit.
|
Within 30 days after index ED visit
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Donna L Carden, MD, MPH, University of Florida
Publikationen und hilfreiche Links
Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Tatsächlich)
3. Mai 2014
Primärer Abschluss (Tatsächlich)
30. November 2015
Studienabschluss (Tatsächlich)
10. März 2017
Studienanmeldedaten
Zuerst eingereicht
4. März 2014
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
4. März 2014
Zuerst gepostet (Schätzen)
6. März 2014
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
5. April 2019
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
3. Januar 2019
Zuletzt verifiziert
1. Januar 2019
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- IRB201400005
- PCORI-1306-01451 (Andere Zuschuss-/Finanzierungsnummer: PCORI)
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .